Our investments accelerate growth and stimulate private sector innovation and investment, giving our partners additional tools to effect change and improve lives. We make investments that align with foundation issue areas from vaccine development to education in the United States.
More on the types of investments we make.
Here you can explore our current and past investments, filtered by issue area or investment type.
The foundation has committed to further support the Global Health Investment Fund model by investing as an anchor LP in Adjuvant. Adjuvant is a private investment fund focused on late-stage life sciences investments to address global health challenges. The Fund invests Read More
Affinivax achieves unprecedented levels of immune response and disease protection by streamlining the process of vaccine design and allowing for multiple antigens to be effectively incorporated in a single vaccine.
News StoryThe foundation invested in the Africa Health Fund to provide capital to support new approaches to improving the quality and accessibility of private healthcare across the continent.
The African Agricultural Capital Fund provides growth capital to companies that boost the productivity and profitability of smallholder farmers in East Africa.
Press Release
AgBiome is focused on discovery and development of biological and transgenic products for crop protection. AgBiome identifies microbes from a wide variety of sources to harness their natural abilities to help crops resist pests and stresses.
Press Release
The Agtech Accelerator is a start-up incubator based in Research Triangle Park, NC focused on fostering entrepreneurship in agriculture, supported by a syndicate of investors, including ARCH Venture Partners, Flagship Ventures, Hatteras Venture Partners, Bayer CropScience, Syngenta Ventures, and others.
Press Release
The foundation invested in Amyris to support the development of new, low-cost technologies for manufacturing compounds to make semi-synthetic artemisinin that can be used in anti-malaria treatments.
Atreca is a biotechnology company that employs its proprietary discovery platform to generate and develop therapeutics based on its ability to rapidly characterize the human adaptive immune response at the single cell level. The Atreca platform enables the high-throughput phylogenetic Read More
News Story
Avanti Finance Private Limited is a Non-Banking Financial Company and financial technology platform in India focused on enabling financial inclusion and sustainable livelihoods through improved access to affordable, livelihoods-purpose credit for unbanked and low-income populations across the country. The foundation Read More
Press Release
Beijing Bio-Institute Biological Products is devoted to the research, development, production, and supply of biological products.
Press Release